Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System

Takahiro Niimura, Yoshito Zamami, Koji Miyata, Takahisa Mikami, Mizuho Asada, Keijo Fukushima, Masaki Yoshino, Satoru Mitsuboshi, Naoto Okada, Hirofumi Hamano, Takumi Sakurada, Rie Matsuoka‐Ando, Fuka Aizawa, Kenta Yagi, Mitsuhiro Goda, Masayuki Chuma, Toshihiro Koyama, Yuki Izawa‐Ishizawa, Hiroaki Yanagawa, Hiromichi Fujino, Yoshihiro Yamanishi, Keisuke Ishizawa

Open source

DOI: 10.1002/jcph.2187
Published: 2022-12-21
Container: The Journal of Clinical Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcph.2187,
  title = {Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System},
  author = {Takahiro Niimura and Yoshito Zamami and Koji Miyata and Takahisa Mikami and Mizuho Asada and Keijo Fukushima and Masaki Yoshino and Satoru Mitsuboshi and Naoto Okada and Hirofumi Hamano and Takumi Sakurada and Rie Matsuoka‐Ando and Fuka Aizawa and Kenta Yagi and Mitsuhiro Goda and Masayuki Chuma and Toshihiro Koyama and Yuki Izawa‐Ishizawa and Hiroaki Yanagawa and Hiromichi Fujino and Yoshihiro Yamanishi and Keisuke Ishizawa},
  year = {2022},
  journal = {The Journal of Clinical Pharmacology},
  doi = {10.1002/jcph.2187},
  url = {https://doi.org/10.1002/jcph.2187}
}

RIS

TY  - JOUR
TI  - Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System
AU  - Takahiro Niimura
AU  - Yoshito Zamami
AU  - Koji Miyata
AU  - Takahisa Mikami
AU  - Mizuho Asada
AU  - Keijo Fukushima
AU  - Masaki Yoshino
AU  - Satoru Mitsuboshi
AU  - Naoto Okada
AU  - Hirofumi Hamano
AU  - Takumi Sakurada
AU  - Rie Matsuoka‐Ando
AU  - Fuka Aizawa
AU  - Kenta Yagi
AU  - Mitsuhiro Goda
AU  - Masayuki Chuma
AU  - Toshihiro Koyama
AU  - Yuki Izawa‐Ishizawa
AU  - Hiroaki Yanagawa
AU  - Hiromichi Fujino
AU  - Yoshihiro Yamanishi
AU  - Keisuke Ishizawa
PY  - 2022
JO  - The Journal of Clinical Pharmacology
DO  - 10.1002/jcph.2187
UR  - https://doi.org/10.1002/jcph.2187
ER  -

APA

Niimura, T., Zamami, Y., Miyata, K., Mikami, T., Asada, M., Fukushima, K., Yoshino, M., Mitsuboshi, S., Okada, N., Hamano, H., Sakurada, T., Matsuoka‐Ando, R., Aizawa, F., Yagi, K., Goda, M., Chuma, M., Koyama, T., Izawa‐Ishizawa, Y., Yanagawa, H., Fujino, H., Yamanishi, Y., & Ishizawa, K. (2022). Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2187

Source records

crossref · retrieved 2026-09-26T08:10:29.681Z